Vaccinations with T-helper type 1 directing adjuvants have different suppressive effects on the development of allergen-induced T-helper type 2 responses

Clinical and Experimental Allergy

Volumn 35, Issue 8, 2005, Pages 1003-1013

  Trujillo Vargas, Claudia M ^a   Mayer, K D ^b   Bickert, T ^a   Palmetshofer, A ^a   Grunewald, S ^a   Ramirez Pineda, J R ^c   Polte, T ^d   Hansen, G ^d   Wohlleben, G ^a   Erb, K J ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b TRUDEAU INSTITUTE   (United States)

^c UNIVERSIDAD DE ANTIOQUIA   (Colombia)

^d MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Adjuvants; Allergy; BCG; Th1 Th2 cells; Vaccination

Indexed keywords

BCG VACCINE; GAMMA INTERFERON; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; INTERLEUKIN 12; OLIGODEOXYNUCLEOTIDE; OVALBUMIN; TUBERCULIN;

ALLERGIC DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BCG VACCINATION; CONTROLLED STUDY; CPG ISLAND; DRUG EFFECT; DRUG EFFICACY; EOSINOPHILIA; FEMALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE; TH2 CELL;

EID: 27744488946     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2005.02287.x     Document Type: Article

References (31)

1. Maddox L, Schwartz DA. The pathophysiology of asthma. Annu Rev Med 2002; 53:477-98.
2. Erb KJ, Wohlleben G. Novel vaccines protecting against the development of allergic disorders: a double-edged sword? Curr Opin Immunol 2002; 14:633-43.
3. Yazdanbakhsh M, Kremsner PG, van Ree R. Allergy, parasites, and the hygiene hypothesis. Science 2002; 296:490-4.
4. Zuany-Amorim C, Sawicka E, Manlius C et al. Suppression of airway eosinophilia by killed Mycobacterium vaccae-induced allergen-specific regulatory T-cells. Nat Med 2002; 8:625-9.
5. Umetsu DT, Akbari O, Dekruyff RH. Regulatory T cells control the development of allergic disease and asthma. J Allergy Clin Immunol 2003; 112:480-7.
6. O'Garra A. Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity 1998; 8:275-83.
7. Erb KJ, Holloway JW, Sobeck A, Moll H, Le Gros G. Infection of mice with Mycobacterium bovis-Bacillus Calmette-Guerin (BCG) suppresses allergen-induced airway eosinophilia. J Exp Med 1998; 187:561-9.
8. Hansen G, Yeung VP, Berry G, Umetsu DT, DeKruyff RH. Vaccination with heat-killed Listeria as adjuvant reverses established allergen-induced airway hyperreactivity and inflammation: role of CD8+ T cells and IL-18. J Immunol 2000; 164:223-30.
9. Wohlleben G, Muller J, Tatsch U et al. Influenza A virus infection inhibits the efficient recruitment of Th2 cells into the airways and the development of airway eosinophilia. J Immunol 2003; 170:4601-11.
10. Trujillo C, Erb KJ. Inhibition of allergic disorders by infection with bacteria or the exposure to bacterial products. Int J Med Microbiol 2003; 293:123-31.
11. Wohlleben G, Erb KJ. Atopic disorders: a vaccine around the corner? Trends Immunol 2001; 22:618-26.
12. Jain VV, Kitagaki K, Businga T et al. CpG-oligodeoxynucleotides inhibit airway remodeling in a murine model of chronic asthma. J Allergy Clin Immunol 2002; 110:867-72.
13. Smit JJ, Loveren HV, Hoekstra MO, Schijf MA, Folkerts G, Nijkamp FP. Mycobacterium vaccae administration during allergen sensitization or challenge suppresses asthmatic features. Clin Exp Allergy 2003; 33:1083-9.
14. Li XM, Srivastava K, Huleatt JW, Bottomly K, Burks AW, Sampson HA. Engineered recombinant peanut protein and heat-killed Listeria monocytogenes coadministration protects against peanut-induced anaphylaxis in a murine model. J Immunol 2003; 170:3289-95.
15. Hattori H, Okano M, Yamamoto T et al. Intranasal application of purified protein derivative suppresses the initiation but not the exacerbation of allergic rhinitis in mice. Clin Exp Allergy 2002; 32:951-9.
16. Grunewald SM, Hahn C, Wohlleben G et al. Infection with influenza A virus leads to flu antigen-induced cutaneous anaphylaxis in mice. J Invest Dermatol 2002; 118:645-51.
17. Hamelmann E, Schwarze J, Takeda K et al. Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography. Am J Respir Crit Care Med 1997; 156:766-75.
18. Lutz MB, Kukutsch N, Ogilvie ALJ et al. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods 1999; 223:77-92.
19. Kline JN, Krieg AM, Waldschmidt TJ, Ballas ZK, Jain V, Businga TR. CpG oligodeoxynucleotides do not require TH1 cytokines to prevent eosinophilic airway inflammation in a murine model of asthma. J Allergy Clin Immunol 1999; 104:1258-64.
20. Brombacher F, Kastelein RA, Alber G. Novel IL-12 family members shed light on the orchestration of Th1 responses. Trends Immunol 2003; 24:207-12.
21. Caux C, Ait-Yahia S, Chemin K et al. Dendritic cell biology and regulation of dendritic cell trafficking by chemokines. Springer Semin Immunopathol 2000; 22:345-69.
22. Cohn L, Homer RJ, Niu N, Bottomly K. T helper 1 cells and interferon gamma regulate allergic airway inflammation and mucus production. J Exp Med 1999; 190:1309-18.
23. Huang TJ, MacAry PA, Eynott P et al. Allergen-specific Th1 cells counteract efferent Th2 cell-dependent bronchial hyperresponsiveness and eosinophilic inflammation partly via IFN-gamma. J Immunol 2001; 166:207-17.
24. Tilg H, Kaser A. Type I interferons and their therapeutic role in Th2-regulated inflammatory disorders. Expert Opin Biol Ther 2004; 4:469-81.
25. Nakane A, Minigawa T. Induction of alpha and beta interferons during the hyporeactive state of gamma interferon by Mycobacterium bovis BCG cell wall fraction in Mycobacterium bovis BCG-sensitized mice. Infect Immun 1982; 36:966-70.
26. + cells with regulatory potential in allergic mice. Eur J Immunol 2004; 34:631-8.
27. Jain W, Businga TR, Kitagaki K, George CL, O'Shaughnessy PT, Kline JN. Mucosal immunotherapy with CpG oligodeoxynucleotides reverses a murine model of chronic asthma induced by repeated antigen exposure. Am J Physiol Lung Cell Mol Physiol 2003; 285:L1137-46.
28. Heikenwalder M, Polymenidou M, Junt T et al. Lymphoid follicle destruction and immunosuppression after repeated CpG oligodeoxynucleotide administration. Nat Med 2004; 10: 187-92.
29. Choi IS, Koh YI. Therapeutic effects of BCG vaccination in adult asthmatic patients: a randomized, controlled trial. Ann Allergy Asthma Immunol 2002; 88:584-91.
30. Shirtcliffe PM, Easthope SE, Weatherall M, Beasley R. Effect of repeated intradermal injections of heat-inactivated Mycobacterium bovis Bacillus Calmette-Guérin in adult asthma. Clin Exp Allergy 2004; 34:207-12.
31. Renz H. Usefulness of mycobacteria in redirecting the immune response in atopic disease. Clin Exp Allergy 2004; 34:167-69.